Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fibrogen Inc (FGEN) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Fibrogen Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 921299.
Total stock buying since 2015: $1,558,665.
Total stock sales since 2015: $220,602,753.
Total stock option exercises since 2015: $24,738,459.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 468,567 | $275,139 | 0 | $0 | 0 | $0 |
| 2024 | 50,000 | $95,450 | 0 | $0 | 0 | $0 |
| 2023 | 0 | $0 | 219,134 | $4,071,990 | 0 | $0 |
| 2022 | 0 | $0 | 6,943 | $107,123 | 0 | $0 |
| 2021 | 3,100 | $35,743 | 49,099 | $1,598,270 | 41,999 | $522,130 |
| 2020 | 27,800 | $988,883 | 146,666 | $5,897,563 | 161,886 | $3,059,897 |
| 2019 | 0 | $0 | 1,029,307 | $48,336,364 | 655,059 | $5,835,259 |
| 2018 | 0 | $0 | 1,359,531 | $73,772,269 | 808,272 | $6,849,677 |
| 2017 | 3,500 | $163,450 | 1,438,950 | $55,095,822 | 1,011,028 | $5,035,041 |
| 2016 | 0 | $0 | 880,582 | $17,119,568 | 456,814 | $1,757,502 |
| 2015 | 0 | $0 | 564,264 | $14,603,784 | 355,358 | $1,678,953 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-08-20 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-08-16 | Kurkijarvi Kalevi (Director) | Sale | 4,000 | 60.17 | 240,700 |
| 2018-08-16 | Kurkijarvi Kalevi (Director) | Option Ex | 4,000 | 2.90 | 11,600 |
| 2018-08-16 | Rosenkranz Roberto Pedro (Director) | Sale | 1,000 | 60.21 | 60,210 |
| 2018-08-16 | Rosenkranz Roberto Pedro (Director) | Option Ex | 1,000 | 9.78 | 9,775 |
| 2018-08-09 | Routti Jorma (Director) | Sale | 6,000 | 60.39 | 362,340 |
| 2018-08-09 | Routti Jorma (Director) | Option Ex | 6,000 | 18.00 | 108,000 |
| 2018-08-02 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 62.93 | 1,247,087 |
| 2018-08-02 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-08-01 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 63.19 | 1,252,299 |
| 2018-08-01 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-07-19 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 64.47 | 1,277,666 |
| 2018-07-19 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-07-19 | Kurkijarvi Kalevi (Director) | Sale | 4,000 | 64.35 | 257,399 |
| 2018-07-19 | Kurkijarvi Kalevi (Director) | Option Ex | 4,000 | 2.90 | 11,600 |
| 2018-07-19 | Rosenkranz Roberto Pedro (Director) | Sale | 1,000 | 64.90 | 64,900 |
| 2018-07-19 | Rosenkranz Roberto Pedro (Director) | Option Ex | 1,000 | 9.78 | 9,775 |
| 2018-07-18 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 65.46 | 1,297,226 |
| 2018-07-18 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-07-09 | Routti Jorma (Director) | Sale | 6,000 | 67.71 | 406,259 |
| 2018-07-09 | Routti Jorma (Director) | Option Ex | 6,000 | 18.00 | 108,000 |
| 2018-07-06 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 65.82 | 1,304,420 |
| 2018-07-06 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-07-05 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 64.31 | 1,274,594 |
| 2018-07-05 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-07-03 | Yu K Peony (Chief Medical Officer) | Sale | 15,645 | 65.00 | 1,016,925 |
| 2018-07-03 | Yu K Peony (Chief Medical Officer) | Option Ex | 15,645 | 14.57 | 228,025 |
| 2018-07-03 | Schoeneck James A (Director) | Sale | 7,639 | 65.00 | 496,535 |
| 2018-07-03 | Schoeneck James A (Director) | Option Ex | 7,639 | 2.90 | 22,153 |
| 2018-06-22 | Schoeneck James A (Director) | Sale | 4,361 | 65.00 | 283,465 |
| 2018-06-22 | Schoeneck James A (Director) | Option Ex | 4,361 | 2.90 | 12,646 |
| 2018-06-21 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 63.74 | 1,263,199 |
| 2018-06-21 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-06-21 | Rosenkranz Roberto Pedro (Director) | Sale | 1,000 | 63.65 | 63,650 |
| 2018-06-21 | Rosenkranz Roberto Pedro (Director) | Option Ex | 1,000 | 9.78 | 9,775 |
| 2018-06-20 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 63.66 | 1,261,514 |
| 2018-06-20 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-06-18 | Kurkijarvi Kalevi (Director) | Sale | 4,000 | 58.19 | 232,760 |
| 2018-06-18 | Kurkijarvi Kalevi (Director) | Option Ex | 4,000 | 2.90 | 11,600 |
| 2018-06-14 | Cotroneo Pat (SVP, Finance and CFO) | Sale | 7,750 | 60.00 | 465,000 |
| 2018-06-14 | Cotroneo Pat (SVP, Finance and CFO) | Option Ex | 7,750 | 25.40 | 196,850 |
| 2018-06-14 | Yu K Peony (Chief Medical Officer) | Sale | 3,422 | 59.20 | 202,582 |
| 2018-06-13 | Cotroneo Pat (SVP, Finance and CFO) | Sale | 2,319 | 57.70 | 133,806 |
| 2018-06-11 | Routti Jorma (Director) | Sale | 6,000 | 57.48 | 344,880 |
| 2018-06-11 | Routti Jorma (Director) | Option Ex | 6,000 | 9.78 | 58,650 |
| 2018-06-08 | Cotroneo Pat (SVP, Finance and CFO) | Sale | 1,011 | 55.55 | 56,161 |
| 2018-06-05 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 55.15 | 1,093,022 |
| 2018-06-05 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-06-04 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 54.79 | 1,085,788 |
| 2018-06-04 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-06-04 | Cotroneo Pat (SVP, Finance and CFO) | Sale | 6,013 | 55.16 | 331,677 |
| 2018-06-04 | Cotroneo Pat (SVP, Finance and CFO) | Option Ex | 6,013 | 19.39 | 116,592 |
| 2018-05-21 | Cotroneo Pat (SVP, Finance and CFO) | Sale | 14,987 | 55.04 | 824,884 |
| 2018-05-21 | Cotroneo Pat (SVP, Finance and CFO) | Option Ex | 14,987 | 22.39 | 335,633 |
| 2018-05-17 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 51.83 | 1,027,226 |
| 2018-05-17 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-05-17 | Kurkijarvi Kalevi (Director) | Sale | 4,000 | 51.83 | 207,320 |
| 2018-05-17 | Kurkijarvi Kalevi (Director) | Option Ex | 4,000 | 2.90 | 11,600 |
| 2018-05-17 | Rosenkranz Roberto Pedro (Director) | Sale | 1,000 | 52.20 | 52,200 |
| 2018-05-17 | Rosenkranz Roberto Pedro (Director) | Option Ex | 1,000 | 9.78 | 9,775 |
| 2018-05-16 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 52.01 | 1,030,793 |
| 2018-05-16 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-05-09 | Routti Jorma (Director) | Sale | 6,000 | 47.10 | 282,600 |
| 2018-05-09 | Routti Jorma (Director) | Option Ex | 6,000 | 9.78 | 58,650 |
| 2018-05-03 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 46.86 | 928,671 |
| 2018-05-03 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-05-02 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 47.33 | 937,886 |
| 2018-05-02 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-04-23 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 33,550 | 2.90 | 97,295 |
| 2018-04-19 | Kurkijarvi Kalevi (Director) | Sale | 4,000 | 47.69 | 190,760 |
| 2018-04-19 | Kurkijarvi Kalevi (Director) | Option Ex | 4,000 | 2.90 | 11,600 |
| 2018-04-19 | Rosenkranz Roberto Pedro (Director) | Sale | 1,000 | 47.70 | 47,700 |
| 2018-04-19 | Rosenkranz Roberto Pedro (Director) | Option Ex | 1,000 | 9.78 | 9,775 |
| 2018-04-18 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 48.83 | 967,772 |
| 2018-04-18 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-04-17 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 48.36 | 958,339 |
| 2018-04-17 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-04-16 | Yu K Peony (Chief Medical Officer) | Sale | 7,500 | 47.85 | 358,875 |
| 2018-04-09 | Routti Jorma (Director) | Sale | 6,000 | 46.35 | 278,130 |
| 2018-04-09 | Routti Jorma (Director) | Option Ex | 6,000 | 5.95 | 35,700 |
| 2018-04-05 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 45.62 | 904,156 |
| 2018-04-05 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-04-04 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 45.95 | 910,676 |
| 2018-04-04 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,320 | 3.60 | 37,152 |
| 2018-03-21 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 51.31 | 1,016,861 |
| 2018-03-21 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,042 | 3.60 | 32,551 |
| 2018-03-20 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 50.79 | 1,006,556 |
| 2018-03-20 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,042 | 3.60 | 32,551 |
| 2018-03-15 | Cotroneo Pat (VP, Finance and CFO) | Sale | 36,094 | 52.66 | 1,900,529 |
| 2018-03-15 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 36,094 | 24.52 | 885,205 |
| 2018-03-15 | Kurkijarvi Kalevi (Director) | Sale | 4,000 | 52.63 | 210,520 |
| 2018-03-15 | Kurkijarvi Kalevi (Director) | Option Ex | 4,000 | 2.90 | 11,600 |
| 2018-03-15 | Rosenkranz Roberto Pedro (Director) | Sale | 1,000 | 52.47 | 52,465 |
| 2018-03-15 | Rosenkranz Roberto Pedro (Director) | Option Ex | 1,000 | 9.78 | 9,775 |
| 2018-03-14 | Yu K Peony (Chief Medical Officer) | Sale | 9,891 | 53.20 | 526,201 |
| 2018-03-13 | Cotroneo Pat (VP, Finance and CFO) | Sale | 5,932 | 54.61 | 323,946 |
| 2018-03-13 | Tamura Toshinari (Director) | Sale | 24,000 | 53.40 | 1,281,480 |
| 2018-03-13 | Tamura Toshinari (Director) | Option Ex | 24,000 | 18.17 | 436,080 |
| 2018-03-13 | Riggs Rory B (Director) | Sale | 12,402 | 54.39 | 674,507 |
| 2018-03-12 | Kearns Thomas F Jr (Director) | Sale | 18,000 | 55.00 | 990,000 |
| 2018-03-12 | Kearns Thomas F Jr (Director) | Option Ex | 18,000 | 3.60 | 64,800 |
| 2018-03-12 | Riggs Rory B (Director) | Sale | 19,693 | 54.98 | 1,082,721 |
| 2018-03-09 | Riggs Rory B (Director) | Sale | 22,905 | 55.75 | 1,276,953 |
| 2018-03-08 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 53.28 | 1,055,942 |
| 2018-03-08 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,319 | 2.98 | 30,699 |
| 2018-03-08 | Cotroneo Pat (VP, Finance and CFO) | Sale | 1,894 | 53.53 | 101,391 |
| 2018-03-07 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 53.34 | 1,057,131 |
| 2018-03-07 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,265 | 2.35 | 24,122 |
| 2018-02-23 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 56.62 | 1,122,055 |
| 2018-02-23 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,265 | 2.35 | 24,122 |
| 2018-02-22 | Neff Thomas B (Chief Executive Officer) | Sale | 19,818 | 57.23 | 1,134,283 |
| 2018-02-22 | Neff Thomas B (Chief Executive Officer) | Option Ex | 10,265 | 2.35 | 24,122 |
| 2018-02-16 | Cotroneo Pat (VP, Finance and CFO) | Sale | 3,960 | 56.48 | 223,660 |
| 2018-02-16 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 3,960 | 18.00 | 71,280 |
| 2018-02-15 | Cotroneo Pat (VP, Finance and CFO) | Sale | 45,540 | 55.77 | 2,539,765 |
| 2018-02-15 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 45,540 | 23.83 | 1,085,218 |
| 2018-02-15 | Kurkijarvi Kalevi (Director) | Sale | 6,000 | 55.91 | 335,430 |
| 2018-02-15 | Kurkijarvi Kalevi (Director) | Option Ex | 6,000 | 2.90 | 17,400 |
| 2018-02-15 | Rosenkranz Roberto Pedro (Director) | Sale | 1,000 | 56.01 | 56,010 |
| 2018-02-15 | Rosenkranz Roberto Pedro (Director) | Option Ex | 1,000 | 9.78 | 9,775 |
| 2018-02-15 | Routti Jorma (Director) | Sale | 6,000 | 55.91 | 335,460 |
| 2018-02-15 | Routti Jorma (Director) | Option Ex | 6,000 | 3.50 | 21,000 |
| 2018-02-14 | Routti Jorma (Director) | Sale | 6,000 | 54.63 | 327,780 |
| 2018-02-14 | Routti Jorma (Director) | Option Ex | 6,000 | 3.50 | 21,000 |
| 2018-02-08 | Yu K Peony (Chief Medical Officer) | Sale | 7,500 | 54.23 | 406,687 |
| 2018-01-30 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 61.53 | 1,188,636 |
| 2018-01-29 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 61.25 | 1,183,227 |
| 2018-01-29 | Yu K Peony (Chief Medical Officer) | Sale | 10,000 | 62.00 | 620,000 |
| 2018-01-26 | Rosenkranz Roberto Pedro (Director) | Sale | 6,000 | 60.00 | 360,000 |
| 2018-01-23 | Rosenkranz Roberto Pedro (Director) | Sale | 1,929 | 50.00 | 96,450 |
| 2018-01-22 | Cotroneo Pat (VP, Finance and CFO) | Sale | 25,000 | 48.70 | 1,217,375 |
| 2018-01-22 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 25,000 | 18.00 | 450,000 |
| 2018-01-22 | Rosenkranz Roberto Pedro (Director) | Sale | 71 | 50.00 | 3,550 |
| 2018-01-19 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 47.32 | 914,185 |
| 2018-01-18 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 47.66 | 920,753 |
| 2018-01-18 | Kurkijarvi Kalevi (Director) | Sale | 6,000 | 47.65 | 285,900 |
| 2018-01-18 | Kurkijarvi Kalevi (Director) | Option Ex | 6,000 | 2.90 | 17,400 |
| 2018-01-18 | Rosenkranz Roberto Pedro (Director) | Sale | 6,000 | 47.73 | 286,368 |
| 2018-01-18 | Rosenkranz Roberto Pedro (Director) | Option Ex | 1,000 | 9.78 | 9,775 |
| 2018-01-05 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 46.56 | 899,504 |
| 2018-01-04 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 48.89 | 944,418 |
| 2017-12-29 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 48.43 | 935,628 |
| 2017-12-28 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 48.43 | 935,628 |
| 2017-12-21 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 45.22 | 873,559 |
| 2017-12-21 | Neff Thomas B (Chief Executive Officer) | Option Ex | 80,000 | 3.33 | 266,640 |
| 2017-12-20 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 43.90 | 848,002 |
| 2017-12-18 | Kurkijarvi Kalevi (Director) | Sale | 2,000 | 42.80 | 85,600 |
| 2017-12-15 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 41.93 | 809,965 |
| 2017-12-14 | Neff Thomas B (Chief Executive Officer) | Sale | 19,318 | 42.79 | 826,655 |
| 2017-12-14 | Yu K Peony (Chief Medical Officer) | Sale | 2,851 | 43.70 | 124,588 |
Insider trading activities including stock purchases, stock sales, and option exercises of FGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Fibrogen Inc (symbol FGEN, CIK number 921299) see the Securities and Exchange Commission (SEC) website.